Biokraft International AB reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 123.1 million compared to SEK 97.01 million a year ago. Revenue was SEK 137.84 million compared to SEK 107.63 million a year ago.

Net loss was SEK 58.24 million compared to SEK 15.17 million a year ago. Basic loss per share from continuing operations was SEK 1.31 compared to SEK 0.32 a year ago. Diluted loss per share from continuing operations was SEK 1.31 compared to SEK 0.32 a year ago.